Friederike Middeke und Twitter - Info zur Person

(1 - 11 von 13

)

Interim Phase III Data Show Praxbind® (idarucizumab) Reverses ...美国商业资讯

www.businesswirechina.com

Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com/Boehringer or. More ... Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com/Boehringer or. More ...

View Site - 文传商讯cn-info.net

www.cn-info.net

AP — Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com AP — Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com ...

Boehringer Ingelheim launches RE-VECTO global ...newswire.co.kr ·

www.newswire.co.kr

Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com/Boehringer › ...

Pradaxa® (dabigatran etexilate) dual therapy showed lower rates of...

mideasteconomist.blog.fc2.com

www.twitter.com/Boehringer Contacts Boehringer Ingelheim GmbH. Corporate Communications Media + PR Friederike Middeke Phone: +

FDA Approves Praxbind® (idarucizumab), Specific ...Yahoo Finance HK

hk.finance.yahoo.com

AP — Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com AP — Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com ...

BOEHRINGER-INGELHEIM-GMB | Business Wire - Via RitzauVia Ritzau

via.ritzau.dk

AP — Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com AP — Friederike Middeke Phone: + – Fax: + – Twitter: http://twitter.com ...

Boehringer Ingelheim Launches RE-COVERY DVT/PEBioSpace

www.biospace.com

Friederike Middeke Phone: + – Fax: + – · Email this · Facebook · Twitter · LinkedIn ... Friederike Middeke Phone: + – Fax: + – · Email this · Facebook · Twitter · LinkedIn ...